艾滋病毒/艾滋病的40年历程

今年6月是描述肺囊虫性肺炎的第一份科学报告发表40周年,肺囊虫性肺炎就是后来众所周知的获得性免疫缺陷综合症(AIDS),即艾滋病。根据美国疾病控制和预防中心的数据,迄今为止全球已有超过3,200万人死于艾滋病,另外有3,800万人感染了可引发艾滋病的人类免疫缺陷病毒(HIV),即艾滋病毒。

Did your plastic surgeon really turn back the clock? Artificial intelligence may be able to quantify how young you actually look after facelift surgery

For most patients, the reasons for having a facelift are simple: to “turn back the clock” for a younger and more attractive appearance. Even during the pandemic year 2020, more than 234,000 patients underwent facelift surgery, according to American Society of Plastic Surgeons (ASPS) statistics.

Editors of MIT Technology Review name Argonne’s Jie Xu as a 2021 Innovator Under 35

The editors of MIT Technology Review have chosen Argonne’s Jie Xu as an Innovator Under 35 for 2021. She is one of only 35 innovators under the age of 35 named to this list. She is being recognized for her research on printable skin-like electronics.

UT/TT Poll: Texans’ Views on Vaccines, Leadership, Legislation and the Future

The latest University of Texas/Texas Tribune poll showed significant differences along party lines on Texans’ attitudes about COVID-19 vaccines: 79% of Democrats report being vaccinated, compared with 47% of Republicans. And about a quarter of Texans (24%) say they are not planning on getting a vaccine.

Are Multiple Sclerosis Drugs Used Early on in the Disease Also Effective Later?

Finding treatments for advanced multiple sclerosis (MS) has been difficult. But new research may help neurologists identify which drugs are best for people with the advanced form of MS called secondary progressive MS. The new study, published in the June 30, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology, found that the more potent disease-modifying drugs are more effective in reducing flare-ups in secondary progressive MS than the less potent drugs that tend to be safer to take. However, the researchers found no difference in how fast the disease progressed between these two types of drugs.

Does Socioeconomic Status Explain Why Black People with MS Have More Disability?

A new study suggests that even when differences in socioeconomic status are taken into consideration, Black people with multiple sclerosis (MS) may be more negatively impacted by the disease than white people with MS. The research is published in the June 30, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study found that Black people with MS had lower scores on certain measures of neurological health, like dexterity and walking tests and showed more evidence of disease progression on brain scans.

Roswell Park Teams Draw More Than $34 Million in Grants Supporting New Research

Even as the COVID-19 pandemic took hold, Roswell Park Comprehensive Cancer Center scientists continued to draw support for their innovative research proposals, garnering more than $34 million in competitive grants from government agencies and private funders. These recent grants fund efforts to improve outcomes for patients with some of the most challenging cancer types — including triple-negative breast cancer, pancreatic cancer and head and neck cancers — and to advance what we know about the impact of COVID-19 in cancer patients.

دراسة مايو كلينك توصلت إلى أن تقنية مخطط كهربية القلب مع الذكاء الاصطناعي قد يستبعدان الإصابة بفيروس كورونا المستجد (كوفيد-19) بسرعة

قد يقدم الذكاء الاصطناعي طريقة لتحديد عدم إصابة الشخص بفيروس فيروس كورونا المستجد (كوفيد-19) بدقة، حيث وجدت دراسة استرجاعية دولية أن الإصابة بفيروس كورونا 2 المسبب لمتلازمة الالتهاب التنفسي الحاد الوخيم (السارز)، وهو الفيروس المسبب لفيروس كورونا المستجد (كوفيد-19)، تُحدِث تغيرات كهربية دقيقة في القلب. ويمكن لتقنية مخطط كهربية القلب المدعومة بالذكاء الاصطناعي اكتشاف هذه التغييرات، ويُحتمل استخدامها كاختبار فحص سريع وموثوق لفيروس كورونا المستجد (كوفيد-19) بهدف استبعاد الإصابة بفيروس كورونا المستجد (كوفيد-19).

Texas Health Informatics Alliance Launches, Opens Registration for its First Conference

The University of Texas Health Science Center at Houston (UTHealth) has joined forces with two other University of Texas System institutions to form the Texas Health Informatics Alliance (THIA), which aims to enhance health informatics across the state through partnerships in research, data, policy, education, standards, and workforce development.

SLAS Discovery’s July Special Edition “Drug Discovery Targeting COVID-19” Now Available

The July edition of SLAS Discovery is a Special Edition featuring the cover article, “Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry” by Lesley-Anne Pearson, Charlotte J. Green, Ph.D., De Lin, Ph.D., Alain-Pierre Petit, Ph.D., David W. Gray, Ph.D., Victoria H. Cowling, Ph.D., and Euan A. F. Fordyce, Ph.D., (Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, UK).

Cutting out the proteins that give SARS-CoV-2 its power

Researchers at Texas Biomedical Research Institute (Texas Biomed) have narrowed down the proteins enabling SARS-CoV-2 to cause disease. Using advanced genetic engineering techniques developed at Texas Biomed, they systematically deleted the genetic code for five of the virus’s accessory proteins, one at a time, to see how each one affected the virus’s ability to spread and cause illness. The research was published online this month in the Journal of Virology.

True Grit? Doesn’t Matter for Resistance Training in Men or Women

A study is the first to examine the relationship between grit and a muscular endurance performance task – specifically, the grueling back squat. The expectation was that a “gritty” person would perform more repetitions in a resistance training set. Interestingly, grit did not predict muscular endurance during the back squat in well-trained men and women. Both males and females independently failed to show a relationship between grit and repetitions performed.

MD Anderson Research Highlights for June 30, 2021

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include expanded use of a targeted therapy for a new group of patients with leukemia, molecular studies yielding novel cancer therapeutic targets, insights into radiation therapy resistance and a community intervention to reduce cervical cancer rates.

Taking cues from nature, breakthrough ‘cellular fluidics’ technology could have sweeping impacts

Inspired by the way plants absorb and distribute water and nutrients, Lawrence Livermore National Laboratory researchers have developed a groundbreaking method for transporting liquids and gases using 3D-printed lattice design and capillary action phenomena.

GW Experts Available to Discuss Returning to the Office This Fall

WASHINGTON (June 30, 2021) — Now that COVID-19 vaccination rates in the United States have gone way up, many employers are calling workers back to the office. However, surveys show that many employees enjoy working from home and do not want…

ACSM / Anthem American Fitness Index to Reveal 2021 Fittest City

For more than a decade, the evidence-based ACSM / Anthem American Fitness Index has recognized the critical role physical activity and city infrastructure play in a city’s overall health and fitness. ACSM and the Anthem Foundation will release the 2021 Fitness Index rankings at 7 a.m. EDT on July 13.

New Jersey Woman Experiences Great Success after Bariatric Surgery Despite COVID-19 Obstacles

Some people who have had bariatric surgery are uncomfortable discussing it, but Melissa Flores, 27, feels differently. After losing over 100 pounds since she underwent gastric sleeve surgery in June 2020, Melissa has become an advocate for this option, sharing her experience with anyone who is interested in her weight loss journey.

First Two-Level Lumbar Disc Replacement Performed In Metro DC, Maryland, And Virginia By Spine Surgeon Dr. Christopher Good

The first two-level lumbar disc replacement was performed in Metro DC, Maryland, and Virginia on Friday, June 25, 2021, by Spine Surgeon Dr. Christopher Good (Virginia Spine Institute) – ending an around-the-world journey for one patient looking for relief to more than ten years of debilitating back pain and offering hope to many others looking for an option beyond a conventional spinal fusion that limits mobility.